fingolimod hydrochloride has been researched along with Encephalitis, Viral in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oel, D; Rigler-Hohenwarter, K; Topakian, R; Trenkler, J | 1 |
| Blanc, CA; Lane, TE; Rosen, H | 1 |
2 other study(ies) available for fingolimod hydrochloride and Encephalitis, Viral
| Article | Year |
|---|---|
Cytomegalovirus Encephalitis Under Fingolimod Mimicking Progressive Multifocal Leukoencephalopathy?
Topics: Adult; Cytomegalovirus Infections; Demyelinating Diseases; Encephalitis, Viral; Fingolimod Hydrochloride; Humans; Leukoencephalopathy, Progressive Multifocal; Male; Sphingosine 1 Phosphate Receptor Modulators | 2021 |
FTY720 (fingolimod) modulates the severity of viral-induced encephalomyelitis and demyelination.
Topics: Animals; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cells, Cultured; Central Nervous System; Demyelinating Diseases; Disease Models, Animal; Encephalitis, Viral; Fingolimod Hydrochloride; Green Fluorescent Proteins; Immunosuppressive Agents; Lymph Nodes; Mice; Mice, Inbred C57BL; Mice, Transgenic; Murine hepatitis virus; Nerve Tissue Proteins; Propylene Glycols; Severity of Illness Index; Sphingosine; T-Lymphocytes, Cytotoxic; Virus Replication | 2014 |